Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin

Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability

(2013) Jiabei Sun et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

The SLC2 (GLUT) family of membrane transporters

(2013) Mike Mueckler et al.   MOLECULAR ASPECTS OF MEDICINE

Expression of glucose transporters in cancers

(2012) Leszek Szablewski   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Conjugation of curcumin with PVP capped gold nanoparticles for improving bioavailability

(2012) Rajesh K. Gangwar et al.   Materials Science & Engineering C-Materials for Biological Applications

Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice

(2011) Feroz Akhtar et al.   BIOTECHNOLOGY ADVANCES

Optimised nano-formulation on the bioavailability of hydrophobic polyphenol, curcumin, in freely-moving rats

(2011) Yin-Meng Tsai et al.   FOOD CHEMISTRY

Mucoadhesive curcumin nanospheres: Biological activity, adhesion to stomach mucosa and release of curcumin into the circulation

(2011) Natthakitta Suwannateep et al.   JOURNAL OF CONTROLLED RELEASE

Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays

(2010) Rachel Airley et al.   ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER

Inhibiting NF-κB activation by small molecules as a therapeutic strategy

(2010) Subash C. Gupta et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer

(2010) Ron Epelbaum et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

NF-κB addiction and its role in cancer: ‘one size does not fit all’

(2010) M M Chaturvedi et al.   ONCOGENE

Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer

(2009) J. Shaikh et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines

(2009) M. S. Squires et al.   MOLECULAR CANCER THERAPEUTICS

Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract

(2009) Ji-Youn Sung et al.   PATHOLOGY RESEARCH AND PRACTICE

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

(2009) M. G. Vander Heiden et al.   SCIENCE

Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)–palmitate nanocarrier for curcumin delivery to cancer cells

(2008) Abhishek Sahu et al.   Acta Biomaterialia

Curcumin and cancer: An “old-age” disease with an “age-old” solution

(2008) Preetha Anand et al.   CANCER LETTERS